Tesofensine (0.25mg/capsule), 60 Capsules
Original price was: $185.99.$120.99Current price is: $120.99.
Tesofensine (NS2330) is a triple monoamine reuptake inhibitor with activity at dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT). By inhibiting transporter-mediated monoamine reuptake, Tesofensine modulates monoaminergic signaling networks and alters… CAS: 195875-84-4 | Formula: C17H23Cl2NO | Content: 15,000 mcg (250 mcg per capsule) | Research use only | Third-party lab tested.
Buy Tesofensine (0.25mg/capsule), 60 Capsules – Swiss Chems USA
Tesofensine (0.25mg/capsule), 60 Capsules — Research Overview
Tesofensine (NS2330) is a triple monoamine reuptake inhibitor with activity at dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT). By inhibiting transporter-mediated monoamine reuptake, Tesofensine modulates monoaminergic signaling networks and alters neurotransmitter-associated regulatory pathways. Its broad transporter interaction profile has made it a valuable research tool for investigating DAT, NET, and SERT pharmacology, transporter-ligand binding dynamics, and the molecular mechanisms governing monoamine transporter function. Research applications include monoamine transporter characterization, monoaminergic signaling pathway investigation, transporter pharmacology, and comparative studies of multi-transporter reuptake inhibitors.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
Tesofensine (0.25mg/capsule), 60 Capsules Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C17H23Cl2NO |
| Synonyms | NS2330, TE-01, (1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane |
| Molar Mass | 328.3 g/mol |
| CAS Number | 195875-84-4 |
| PubChem CID | 11370864 |
| Total Compound Content | 15,000 mcg (250 mcg per capsule) |
| Shelf Life | 36 months |
Tesofensine (0.25mg/capsule), 60 Capsules Research Applications
Tesofensine is a tropane-derived triple monoamine reuptake inhibitor with nanomolar affinity for dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT). Simultaneous inhibition of all three transporters modulates monoamine transporter activity and influences downstream monoaminergic signaling networks through a distinct multi-transporter pharmacological profile. This broad transporter interaction pattern differentiates Tesofensine from selective monoamine transporter inhibitors and has established it as a valuable research tool for investigating DAT, NET, and SERT pharmacology, transporter-ligand binding dynamics, and the molecular mechanisms governing monoamine transporter function. Research applications include monoamine transporter characterization, monoaminergic signaling pathway investigation, transporter pharmacology, and comparative studies of multi-transporter reuptake inhibitors. Supplied in 250 mcg capsules. Independently third-party HPLC-tested; COA available per batch.
Tesofensine (0.25mg/capsule), 60 Capsules Lab Results & Certificates of Analysis
Third-party analytical reports associated with this research compound:
Tesofensine (0.25mg/capsule), 60 Capsules Frequently Asked Questions
How does Tesofensine’s transporter interaction profile differ from selective monoamine reuptake inhibitors?
Tesofensine exhibits nanomolar affinity for dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT), providing a broad multi-transporter interaction profile. Unlike compounds that primarily target a single transporter system, Tesofensine enables investigation of transporter pharmacology across multiple monoaminergic pathways simultaneously. This characteristic has made it a valuable research tool for studying transporter selectivity, ligand-transporter interactions, and comparative mechanisms of monoamine reuptake inhibition.
Why is Tesofensine useful for multi-transporter pharmacology research?
Because Tesofensine interacts with DAT, NET, and SERT within a single molecular framework, it provides a useful model for examining the relationship between transporter occupancy, transporter selectivity, and downstream monoaminergic signaling processes. Experimental investigations frequently utilize Tesofensine to explore transporter interaction networks, multi-target pharmacology, and mechanistic differences between selective and broad-spectrum monoamine transporter inhibitors.
What pharmacological properties distinguish Tesofensine from other transporter inhibitors?
Tesofensine combines high-affinity interactions with DAT, NET, and SERT together with a well-characterized transporter binding profile. These properties have established it as a valuable reference compound for investigations involving monoamine transporter biology, transporter-ligand binding dynamics, structure-activity relationships, and mechanistic studies of multi-transporter inhibition systems. Its broad activity across multiple transporter classes continues to support research into monoaminergic signaling and transporter pharmacology.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
| Weight | 3 lbs |
|---|
Reviews
There are no reviews yet.